Bas.
We have a serious IPR-problem. About 1 000 000 patents worldwide are dealing with genetic or stem cell or other microbiological therapies, that monopolize the rights on anti-aging technologies into the hands of few global players.
So, if only ONE of the 1 million patents would be indeed helpful to stop and/or reverse aging, you cannot get this therapy because you never get enough money to pay the horrible expensive therapy (think, the monopolist will earn much money and increase his income and push the price of his stocks endlessly high - the company will certainly not think at the destiny of the mankind !!!) -- and besides, the entire research and development activities on this particular medicin-technologie will size down. At the same moment, when the communities of research instituts (or universities) get knowledge of an important patent in a particular application, the research efforts in this sphere will stop. They are anxious to have to pay licence-fees.
If you do not believe what I wrote, please take a look to some insider-reports at the internet.
E. (sorry bout my insufficient English;-)